Your browser doesn't support javascript.
loading
Pediatric midline H3K27M-mutant tumor with disseminated leptomeningeal disease and glioneuronal features: case report and literature review.
Navarro, Ralph E; Golub, Danielle; Hill, Travis; McQuinn, Michelle W; William, Christopher; Zagzag, David; Hidalgo, Eveline Teresa.
Afiliação
  • Navarro RE; Division of Pediatric Neurosurgery, Department of Neurosurgery, NYU Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  • Golub D; Department of Neurosurgery, Zucker School of Medicine at Hofstra/Northwell, Northwell Health, 300 Community Drive, 9 Tower, Manhasset, NY, 11030, USA. Dgolub1@northwell.edu.
  • Hill T; Division of Pediatric Neurosurgery, Department of Neurosurgery, NYU Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  • McQuinn MW; Division of Pediatric Neurosurgery, Department of Neurosurgery, NYU Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  • William C; Department of Pathology, NYU Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  • Zagzag D; Division of Pediatric Neurosurgery, Department of Neurosurgery, NYU Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  • Hidalgo ET; Department of Pathology, NYU Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
Childs Nerv Syst ; 37(7): 2347-2356, 2021 07.
Article em En | MEDLINE | ID: mdl-32989496
ABSTRACT

BACKGROUND:

H3K27M-mutant midline lesions were recently reclassified by the World Health Organization (WHO) as "diffuse midline glioma" (DMG) based entirely on their molecular signature. DMG is one of the most common and most lethal pediatric brain tumors; terminal progression is typically caused by local midbrain or brainstem progression, or secondary leptomeningeal dissemination. H3K27M mutations have also been infrequently associated with a histologically and prognostically diverse set of lesions, particularly spinal masses with early leptomeningeal spread. CASE PRESENTATION A 15-year-old girl after 1 week of symptoms was found to have a T2/FLAIR-hyperintense and contrast-enhancing thalamic mass accompanied by leptomeningeal enhancement along the entire neuraxis. Initial infectious workup was negative, and intracranial biopsy was inconclusive. Spinal arachnoid biopsy revealed an H3K27M-mutant lesion with glioneuronal features, classified thereafter as DMG. She received craniospinal irradiation with a boost to the thalamic lesion. Imaging 1-month post-radiation demonstrated significant treatment response with residual enhancement at the conus.

CONCLUSIONS:

This case report describes the unique presentation of an H3K27M-mutant midline lesion with significant craniospinal leptomeningeal spread on admission and atypical glioneuronal histopathological markers. With such florid leptomeningeal disease, spinal dural biopsy should be considered earlier given its diagnostic yield in classifying the lesion as DMG. Consistent with similar prior reports, this lesion additionally demonstrated synaptophysin positivity-also potentially consistent with a diagnosis of diffuse leptomeningeal glioneuronal tumor (DLGNT). In atypical DMG cases, particularly with leptomeningeal spread, further consideration of clinical and histopathological context is necessary for accurate diagnosis and prognostication.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma / Neoplasias Meníngeas Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Adolescent / Child / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma / Neoplasias Meníngeas Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Adolescent / Child / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article